Stratification of gastric cancer risk based on family history with cost-effectiveness of opportunistic endoscopic screening: a hospital-based cross-sectional study (SIGES)
- 1Gastric Cancer Center, Department of General Surgery, West China Hospital, Sichuan University , ,
- 2Health Management Center, General Practice Medical Center, West China Hospital, Sichuan University , ,
- 3Department of General Practice (Premium Medical Center/International Medical Center), West China Hospital, Sichuan University , ,
Abstract
Objectives: The strategy for opportunistic endoscopic screening driven by family history of gastric cancer needs to be optimized in a tailored manner through further risk stratification.
Methods: A hospital-based cross-sectional study included health check-up controls and gastric cancer patients at West China Hospital, Sichuan University. Demographic characteristics, comorbidities, family history of malignancies, and serology were analyzed for associations with gastric cancer risk. Associations between family history of gastric cancer and incident gastric cancer risk were assessed, and a rapid cost-effectiveness analysis was performed.
Results: In total, 58,218 observations were analyzed, including 619 gastric cancer patients. Family history of gastric cancer was an independent risk factor for gastric cancer (adjusted odds ratio [aOR] = 5.59, 95% CI 3.81–8.20) and was associated with an increased risk of upper digestive tract benign comorbidities (aOR = 1.51, 95% CI 1.09–2.71). For persons with a family history of gastric cancer who were older than 40 years (odds ratio [OR] = 2.36, 95% CI 1.29–4.32), endoscopic screening could be mildly recommended in general practice. Endoscopic screening should be moderately recommended for those with a family history of gastric cancer if they were older than 60 years (OR = 8.90, 95% CI 3.84–20.61) and strongly recommended if they also had upper digestive tract benign comorbidities (OR = 16.78, 95% CI 7.03–40.06), seropositivity for carcinoembryonic antigen (CEA) and/or carbohydrate antigen 19-9 (CA19-9) (OR = 20.77, 95% CI 9.15–47.14), or anemia (OR = 80.11, 95% CI 33.07–194.05). A rapid cost-effectiveness analysis indicated that moderate-to-strong recommendations were preferred, but based on willingness-to-pay considerations, mild-to-strong recommendations had a considerable detection rate for gastric cancer. Sensitivity analysis yielded consistent findings for decision-making.
Conclusions: Family history of gastric cancer is an independent risk factor for gastric cancer. Optimized risk stratification based on family history can improve the cost-effectiveness of detecting gastric cancer. The mechanism by which a family history of gastric cancer increases gastric cancer risk and a more tailored family history-driven endoscopic screening strategy require further investigation.
Related
- Histopathological Spectrum and Yield of Advanced Neoplasia in Opportunistic Colonoscopy Without Organised Screening: A Single-Centre Cross-Sectional Study from Western Romania
- Federated learning for privacy-preserving opportunistic screening of lumbar-spine DXA-defined osteoporotic-level bone mineral density using chest radiographs: A multi-center independent validation study
- Real-World Validation of an AI-Based Opportunistic Osteoporosis Risk Stratification Tool Using Chest Radiographs in a Male-Predominant Cohort.
- Effectiveness of health mediation to promote organised cancer screening among underserved and under-screened populations in Marseille, France: findings from a repeated cross-sectional survey.
- Potential to improve early detection of lung cancer through expansion of focused and opportunistic screening approaches: a scoping review focusing on potential expansion of screening risk factors and adoption of artificial intelligence models.
BibTeX
@article{li2026stratification,
title = {{Stratification of gastric cancer risk based on family history with cost-effectiveness of opportunistic endoscopic screening: a hospital-based cross-sectional study (SIGES)}},
author = {Zhuo-Yu Li and Wen Xiang and Yan Huang and Xin-Zu Chen},
journal = {Frontiers in oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.1902158},
url = {https://europepmc.org/article/PMC/PMC13671984},
note = {CC BY},
}
RIS
TY - JOUR
TI - Stratification of gastric cancer risk based on family history with cost-effectiveness of opportunistic endoscopic screening: a hospital-based cross-sectional study (SIGES)
AU - Zhuo-Yu Li
AU - Wen Xiang
AU - Yan Huang
AU - Xin-Zu Chen
PY - 2026
DA - 2026/10/02
JO - Frontiers in oncology
DO - 10.3389/fonc.2026.1902158
UR - https://europepmc.org/article/PMC/PMC13671984
AB - Objectives: The strategy for opportunistic endoscopic screening driven by family history of gastric cancer needs to be optimized in a tailored manner through further risk stratification. Methods: A hospital-based cross-sectional study included health check-up controls and gastric cancer patients at West China Hospital, Sichuan University. Demographic characteristics, comorbidities, family history of malignancies, and serology were analyzed for associations with gastric cancer risk. Associations between family history of gastric cancer and incident gastric cancer risk were assessed, and a rapid cost-effectiveness analysis was performed. Results: In total, 58,218 observations were analyzed, including 619 gastric cancer patients. Family history of gastric cancer was an independent risk factor for gastric cancer (adjusted odds ratio [aOR] = 5.59, 95% CI 3.81–8.20) and was associated with an increased risk of upper digestive tract benign comorbidities (aOR = 1.51, 95% CI 1.09–2.71). For persons with a family history of gastric cancer who were older than 40 years (odds ratio [OR] = 2.36, 95% CI 1.29–4.32), endoscopic screening could be mildly recommended in general practice. Endoscopic screening should be moderately recommended for those with a family history of gastric cancer if they were older than 60 years (OR = 8.90, 95% CI 3.84–20.61) and strongly recommended if they also had upper digestive tract benign comorbidities (OR = 16.78, 95% CI 7.03–40.06), seropositivity for carcinoembryonic antigen (CEA) and/or carbohydrate antigen 19-9 (CA19-9) (OR = 20.77, 95% CI 9.15–47.14), or anemia (OR = 80.11, 95% CI 33.07–194.05). A rapid cost-effectiveness analysis indicated that moderate-to-strong recommendations were preferred, but based on willingness-to-pay considerations, mild-to-strong recommendations had a considerable detection rate for gastric cancer. Sensitivity analysis yielded consistent findings for decision-making. Conclusions: Family history of gastric cancer is an independent risk factor for gastric cancer. Optimized risk stratification based on family history can improve the cost-effectiveness of detecting gastric cancer. The mechanism by which a family history of gastric cancer increases gastric cancer risk and a more tailored family history-driven endoscopic screening strategy require further investigation.
SN - 2234-943X
ER -